Madrigal Pharmaceuticals (MDGL) Change in Inventory (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Change in Inventory data on file, last reported at $22.2 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $22.2 million, up 4.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.0 million (down 30.15% YoY), and the FY2025 annual result was $37.0 million, up 8.54% from the prior year.
• Change in Inventory advanced to $22.2 million in Q1 2026 per MDGL's latest filing, from $1.7 million in the prior quarter.
• Over five years, Change in Inventory peaked at $25.4 million in Q4 2024 and troughed at $854000.0 in Q1 2024.
• A 3-year average of $10.4 million and a median of $6.2 million in 2024 frame the typical range for Change in Inventory.
• On a YoY basis, Change in Inventory climbed as much as 2379.27% in 2025 and fell as far as 93.18% in 2025.
• A 3-year view of Change in Inventory shows it stood at $25.4 million in 2024, then tumbled by 93.18% to $1.7 million in 2025, then jumped by 1183.23% to $22.2 million in 2026.
• Business Quant data shows MDGL's Change in Inventory at $22.2 million in Q1 2026, $1.7 million in Q4 2025, and $5.8 million in Q3 2025.